A KAIST research team presented a novel method for improving medication treatment for liver cancer using Systems Biology, combining research from information technology and the life sciences. Professor Kwang-Hyun Cho in the Department of Bio and Brain Engineering at KAIST conducted the research in collaboration with Professor Jung-Hwan Yoon in the Department of Internal Medicine...
Tag: <span>Liver cancer</span>
Post
Scrib protein identified as a natural suppressor of liver cancer
Dr. Satya Ande (left) and Research Assistant Jinling Yuan. A protein that typically helps keep cells organized and on task becomes a tumor suppressor in the face of liver cancer, scientists say. The protein Scrib, which is emerging as both a tumor suppressor and oncogene depending on the cancer type, appears in liver cancer to migrate out of...
Post
Deworming pill may be effective in treating liver cancer
Metastatic hepatocellular carcinoma. Hepatocellular carcinoma (HCC), a cancer associated with underlying liver disease and cirrhosis that often only becomes symptomatic when it is very advanced, is the second leading cause of cancer deaths around the world, and yet it has no effective treatment. As with other conditions without treatments, the data that scientists need...
Post
Immune cell therapy on liver cancer using interferon beta produced with stem cells
(A) Bio-imaging analysis to evaluate the therapeutic effect of iPS-ML producing IFN-β on metastatic liver cancer. (B) Quantification of the image data shown in A. (C) Histological data indicating migration of iPS-ML (PKH26, red) into …more Causes of the most common form of liver cancer, hepatocellular carcinoma (HCC), include hepatitis B or C, cirrhosis, obesity,...